Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database

被引:12
作者
Suga, Yukio [1 ,2 ]
Uchida, Mayako [2 ,3 ]
Suzuki, Shinya [2 ,4 ]
Sugawara, Hideki [2 ,5 ]
Torigoe, Kazuhiro [2 ,6 ]
Futamura, Akihiko [2 ,7 ]
Uesawa, Yoshihiro [2 ,8 ]
Nakagawa, Takayuki [2 ,9 ]
Takase, Hisamitsu [2 ,10 ]
机构
[1] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Dept Clin Drug Informat, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan
[2] Japanese Soc Pharmaceut Palliat Care & Sci, Res Promot Comm, Osaka 5500001, Japan
[3] Osaka Univ Pharmaceut Sci, Educ & Res Ctr Clin Pharm, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan
[4] Natl Canc Ctr Hosp East, Dept Pharm, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[5] Kagoshima Univ Hosp, Dept Clin Pharm & Pharmacol, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan
[6] Hoshi Univ, Div Appl Pharmaceut Educ & Res, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan
[7] Fujita Hlth Univ, Dept Pharm, Nanakuri Mem Hosp, 424-1 Tsu, Tsu, Mie 5141295, Japan
[8] Meiji Pharmaceut Univ, Dept Med Mol Informat, 2-522-1 Noshio, Tokyo 2048588, Japan
[9] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan
[10] Tama Nagayama Hosp, Nippon Med Sch, Tama Ku, Tokyo 2068512, Japan
基金
日本学术振兴会;
关键词
opioid analgesic; Japanese Adverse Drug Event Report; adverse event; proper use; opioid-related death; ORAL MORPHINE; RISK-FACTORS; RESPIRATORY DEPRESSION; TRANSDERMAL FENTANYL; CANCER PAIN; OVERDOSE; DEATHS; MULTICENTER; MANAGEMENT; MORTALITY;
D O I
10.1248/bpb.b18-00997
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Opioid analgesics have greatly contributed to the advancement of pain management. However, although opioids have been appropriately used in Japan, they rarely induce serious adverse events, such as respiratory depression. The present study aimed to investigate the temporal changes in the occurrence of opioid-related adverse events and deaths between 2004 and 2017 in Japan using the Japanese Adverse Drug Event Report (JADER) database. We analyzed the following points using data extracted from JADER website: 1) temporal changes in the number and proportion of opioid-related adverse event reports; 2) temporal changes in the number of morphine-, oxycodone-, and fentanyl-related adverse event reports per annual consumption; and 3) cases in which the reported outcome following opioid-related adverse events was death. Our results showed no dramatic changes in the overall incidence of opioid-related adverse events, despite the temporal changes in the annual consumption and shared component of each opioid during the survey period. However, the number and rate of fentanyl-related adverse events and their outcome "death" increased since 2010, being the highest among all adverse event including those related to morphine and oxycodone. Outcome "death" by fentanyl-related adverse events was caused mainly due to respiratory depression. These findings suggest that, although opioid-related adverse events can be controlled through proper monitoring and management by medical personnel in Japan, extra caution should be continuously paid for the rare but serious fentanyl-induced adverse events.
引用
收藏
页码:801 / 806
页数:6
相关论文
共 50 条
[31]   State Policies for Prescription Drug Monitoring Programs and Adverse Opioid-related Hospital Events [J].
Wen, Katherine ;
Johnson, Phyllis ;
Jeng, Philip J. ;
Schackman, Bruce R. ;
Bao, Yuhua .
MEDICAL CARE, 2020, 58 (07) :610-616
[32]   Drug-induced hyperglycemia in the Japanese Adverse Drug Event Report database: association of evelolimus use with diabetes [J].
Konishi, Hiromi ;
Shirakawa, Jun ;
Arai, Masanori ;
Terauchi, Yasuo .
ENDOCRINE JOURNAL, 2019, 66 (06) :571-574
[33]   A Pharmacovigilance Study on Psychotropic Agent-Induced Urinary Retention Using the Japanese Adverse Drug Event Report Database [J].
Uekusa, Shusuke ;
Mogi, Keika ;
Ota, Yuki ;
Hanai, Yuki ;
Kitagawa, Kohei ;
Yoshio, Takashi ;
Matsuo, Kazuhiro .
DRUGS-REAL WORLD OUTCOMES, 2024, 11 (04) :691-700
[34]   Analysis of the frequency of ceftriaxone-induced encephalopathy using the Japanese Adverse Drug Event Report database [J].
Yamada, Tomoyuki ;
Mitsuboshi, Satoru ;
Suzuki, Kaoru ;
Nishihara, Masami ;
Neo, Masashi .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (04) :1067-1071
[35]   Disproportionality Analysis of Stomatitis Associated with Anticancer Drugs Using the Japanese Adverse Drug Event Report Database [J].
Hosonaka, Kousuke ;
Yamaoka, Kenta ;
Ikeda, Naoe ;
Uchida, Mayako ;
Uesawa, Yoshihiro ;
Takahashi, Kazushige ;
Shimizu, Tadashi .
ONCOLOGY, 2024, 102 (09) :810-817
[36]   Analysis of the frequency of ceftriaxone-induced encephalopathy using the Japanese Adverse Drug Event Report database [J].
Tomoyuki Yamada ;
Satoru Mitsuboshi ;
Kaoru Suzuki ;
Masami Nishihara ;
Masashi Neo .
International Journal of Clinical Pharmacy, 2022, 44 :1067-1071
[37]   Influence factors of metronidazole-related CNS disorders: an analysis of the Japan adverse drug event report and FDA adverse event reporting system [J].
Takada, Keisuke ;
Enoki, Yuki ;
Samura, Masaru ;
Igarashi, Yuki ;
Taguchi, Kazuaki ;
Tanikawa, Koji ;
Matsumoto, Kazuaki .
EXPERT OPINION ON DRUG SAFETY, 2025,
[38]   Disproportionality Analysis on Hypothyroidism With Roxadustat Using the Japanese Adverse Drug Event Database [J].
Kouki, Yasunobu ;
Okada, Naoto ;
Saga, Kosuke ;
Ozaki, Masakazu ;
Saisyo, Atsuyuki ;
Kitahara, Takashi .
JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (10) :1141-1146
[39]   Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases [J].
Kazuyo Shimada ;
Shiori Hasegawa ;
Satoshi Nakao ;
Ririka Mukai ;
Kiyoka Matsumoto ;
Mizuki Tanaka ;
Hiroaki Uranishi ;
Mayuko Masuta ;
Shohei Nishida ;
Shinya Shimizu ;
Yuichi Hayashi ;
Akio Suzuki ;
Mitsuhiro Nakamura .
Cancer Chemotherapy and Pharmacology, 2019, 84 :1097-1105
[40]   Alpelisib-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) pharmacovigilance study [J].
Li, Yun ;
Li, Hang ;
Xiang, Zhongyuan .
HELIYON, 2024, 10 (06)